The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis - 14/12/17
Doi : 10.1016/j.jaad.2017.03.027
Lavanya Mittal, BA, Victoria P. Werth, MD ⁎ 
Corporal Michael J. Crescenz (Philadelphia) Veterans Affairs Medical Center, Philadelphia, Pennsylvania
Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
∗Correspondence to: Victoria P. Werth, MD, Department of Dermatology, University of Pennsylvania, Perelman Center for Advanced Medicine, Suite 1-330A 3400 Civic Center Blvd, Philadelphia, PA 19104Department of DermatologyUniversity of PennsylvaniaPerelman Center for Advanced MedicineSuite 1-330A 3400 Civic Center BlvdPhiladelphiaPA19104
| Funding sources: This work was supported by the US Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development and Biomedical Laboratory Research and Development) Merit Review 5 I01 BX000706-04 (Dr Werth) and by the US Department of Health and Human Services and the National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) R21 AR066286 (Dr Werth). |
|
| Conflicts of interest: None declared. |
© 2017
Publié par Elsevier Masson SAS.
Vol 77 - N° 2
P. 374-377 - août 2017 Retour au numéro
Article précédent
- Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)
- Andrew Blauvelt, Kim A. Papp, Mark G. Lebwohl, Lawrence J. Green, Sylvia Hsu, Varsha Bhatt, Shipra Rastogi, Radhakrishnan Pillai, Robert Israel
- Update on sunscreens distributed by major US retailers that meet American Academy of Dermatology recommendations
- Ariel E. Eber, Frances M. Walocko, John Tsatalis, Marina Perper, Jessica Cervantes, Siri Choragudi, Keyvan Nouri
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?